English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1985]
News [3223]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Research lays a foundation for prevention of the most common childhood cancer
Research lays a foundation for prevention of the most common childhood cancer
Stem cell discoveries hold potential to improve cancer treatment
Stem cell discoveries hold potential to improve cancer treatment
Magnesium is essential for the immune system, including in the fight against cancer
Magnesium is essential for the immune system, including in the fight against cancer
Identification of a novel therapeutic target in multiple myeloma
Identification of a novel therapeutic target in multiple myeloma
New research raises awareness of the dangers of septic shock in blood cancer patients in USA
New research raises awareness of the dangers of septic shock in blood cancer patients in USA
Survival rate of adult patients with relapsed acute lymphoblastic leukaemia after haematopoietic cell transplantation has steadily increased over the past two decades
Survival rate of adult patients with relapsed acute lymphoblastic leukaemia after haematopoietic cell...
Obscure protein is spotlighted in fight against leukaemia
Obscure protein is spotlighted in fight against leukaemia
Protecting people with cancer from COVID-19: New recommendations from cancer guidelines organisation
Protecting people with cancer from COVID-19: New recommendations from cancer guidelines organisation
Aberrant splicing of CD22 in acute lymphoblastic leukaemia underlies resistance to immunotherapy
Aberrant splicing of CD22 in acute lymphoblastic leukaemia underlies resistance to immunotherapy
Daratumumab in multiple myeloma: Reassessment shows hint of considerable added benefit
Daratumumab in multiple myeloma: Reassessment shows hint of considerable added benefit
<1...5859606162...323>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top